IN2014CN03951A - - Google Patents

Info

Publication number
IN2014CN03951A
IN2014CN03951A IN3951CHN2014A IN2014CN03951A IN 2014CN03951 A IN2014CN03951 A IN 2014CN03951A IN 3951CHN2014 A IN3951CHN2014 A IN 3951CHN2014A IN 2014CN03951 A IN2014CN03951 A IN 2014CN03951A
Authority
IN
India
Prior art keywords
terpenoid
ophthalmological
inhibitory activity
aqueous composition
suppressing
Prior art date
Application number
Other languages
English (en)
Inventor
Yasuko Matsumura
Chinatsu Furumiya
Masashi Itoh
Original Assignee
Rohto Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharma filed Critical Rohto Pharma
Publication of IN2014CN03951A publication Critical patent/IN2014CN03951A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IN3951CHN2014 2011-11-01 2012-10-31 IN2014CN03951A (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011240145 2011-11-01
PCT/JP2012/078126 WO2013065719A1 (ja) 2011-11-01 2012-10-31 眼科用水性組成物

Publications (1)

Publication Number Publication Date
IN2014CN03951A true IN2014CN03951A (enrdf_load_html_response) 2015-09-04

Family

ID=48192064

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3951CHN2014 IN2014CN03951A (enrdf_load_html_response) 2011-11-01 2012-10-31

Country Status (5)

Country Link
US (1) US20140296348A1 (enrdf_load_html_response)
JP (2) JP6313598B2 (enrdf_load_html_response)
CA (1) CA2853233A1 (enrdf_load_html_response)
IN (1) IN2014CN03951A (enrdf_load_html_response)
WO (1) WO2013065719A1 (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2853233A1 (en) * 2011-11-01 2013-05-10 Rohto Pharmaceutical Co., Ltd. Ophthalmological aqueous composition
JP6081173B2 (ja) * 2011-12-12 2017-02-15 ロート製薬株式会社 眼科用水性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003146892A (ja) * 2001-11-08 2003-05-21 Rohto Pharmaceut Co Ltd 洗浄剤
JP4953650B2 (ja) * 2005-02-09 2012-06-13 ロート製薬株式会社 プラノプロフェン含有組成物
MX2009003042A (es) * 2006-09-28 2009-04-02 Alcon Res Ltd Composiciones farmaceuticas acuosas auto-preservadas.
JP5314349B2 (ja) * 2007-07-25 2013-10-16 ロート製薬株式会社 眼科用組成物
JP4777477B2 (ja) * 2009-09-30 2011-09-21 ロート製薬株式会社 点眼剤
CA2853233A1 (en) * 2011-11-01 2013-05-10 Rohto Pharmaceutical Co., Ltd. Ophthalmological aqueous composition

Also Published As

Publication number Publication date
JP6313598B2 (ja) 2018-04-18
JP6253756B2 (ja) 2017-12-27
JPWO2013065719A1 (ja) 2015-04-02
US20140296348A1 (en) 2014-10-02
CA2853233A1 (en) 2013-05-10
JP2017052803A (ja) 2017-03-16
WO2013065719A1 (ja) 2013-05-10

Similar Documents

Publication Publication Date Title
IN2014CN03950A (enrdf_load_html_response)
IL235966B (en) Aqueous compositions with a ph level of 6 containing anti-Baffr antibody without fucosylation for use in the treatment of autoimmune diseases
WO2013075826A3 (de) Verwendung von isosorbidcaprylaten/capraten in deodorantien und antiperspirantien
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
IL231591A0 (en) Converted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
MY172021A (en) Rsv antiviral compounds
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
PL2583555T3 (pl) Zastosowanie kompozycji o działaniu biobójczym do preparatów wodnych oraz sposób stabilizowania względem bakterii takich preparatów wodnych
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
PH12014502187A1 (en) Cdr-modified anti-siglec-15 antibody
MX2015011359A (es) Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2).
MX2015012526A (es) Inhibodores macrociclicos de cinasa rip2.
WO2013045270A3 (en) Antiperspirant compositions and method for reducing perspiration
EP2608795A4 (en) SYNERGISTIC FUNGICIDE COMPOSITION
IN2014MN02484A (enrdf_load_html_response)
IL224029A (en) Triazine and pyrimidine compounds, preparations containing them and their use in the treatment of insects
PH12017500516A1 (en) Compositions
IN2014CN03951A (enrdf_load_html_response)
MX341189B (es) Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora.
PH12012502054A1 (en) Dithiinopyridazine-dion derivatives
MX2012008438A (es) Procedimientos de preparacion de dispersiones acuosas basadas en poliuretano-ureas.
ZA201500285B (en) Biocidal compositions and their use in the control of microorganisms in aqueous and water containing systems
WO2012069061A3 (en) A shaving composition for pseudofolliculitis barbae treatment
PH12013500497A1 (en) Composition for improving brain function and method for improving brain function